NIBEC Co., Ltd. (KOSDAQ:138610)

South Korea flag South Korea · Delayed Price · Currency is KRW
21,350
+650 (3.14%)
At close: May 13, 2025, 3:30 PM KST
26.48%
Market Cap 235.26B
Revenue (ttm) 24.55B
Net Income (ttm) -9.33B
Shares Out 11.02M
EPS (ttm) -897.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 96,537
Average Volume 195,791
Open 20,700
Previous Close 20,700
Day's Range 20,300 - 21,600
52-Week Range 12,800 - 25,850
Beta 1.05
RSI 58.37
Earnings Date May 14, 2025

About NIBEC

NIBEC Co., Ltd., a healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally. It offers dental ointment, peptide containing dental bone graft materials, regenerative biomaterials, tooth whitening, tooth desensitizer, herbal toothpaste, and cosmetic products. The company was founded in 2000 and is headquartered in Jincheon-gun, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2000
Employees 96
Stock Exchange KOSDAQ
Ticker Symbol 138610
Full Company Profile

Financial Performance

In 2024, NIBEC's revenue was 24.55 billion, an increase of 56.33% compared to the previous year's 15.70 billion. Losses were -9.33 billion, 48.4% more than in 2023.

Financial Statements

News

There is no news available yet.